Contract Development And Manufacturing Organizations (CDMO)

Kymos Acquires Germany’s Prolytic

Spanish contract laboratory company Kymos has boosted its European presence with the takeover of Germany’s Prolytic. Financial details were not disclosed.

Advancing Sustainable Chemical Solutions

Without products based directly or indirectly on chemicals, life as we know it would be unsustainable. According to various sources, more than 95% of the products around us are either made by the chemical industry or involve at least one chemical process step in their manufacture.

High Standards and Innovation Experience

As a production and innovation partner, JRS Contract Manufacturing supports those involved in special projects in product development, series start-ups, implementation of marketing-relevant product features, process optimization or capacity expansion.

The Rise of HPAPI Molecules

For biopharma leaders it is more critical than ever to secure the capabilities to contain, handle, develop and manufacture highly potent APIs.

Hovione Appoints Jean-Luc Herbeaux as Chief Operating Officer

Jean-Luc Herbeaux has been appointed as Chief Operating Officer (COO) of Hovione, effective May 1, 2020.

Chemical Process Research and Development

Agrochemical and Custom Manufacturing Industry: Connected Fates

The fate of the agrochemical innovation, development, product launch and production are strongly linked to the parallel development of the fine chemicals and custom manufacturing industry.

AGC Expands Spanish Facilities

Patient Centricity: The New Nexus for CDMOs

Rentschler Biopharma Extends Japanese Pact

German biopharmaceuticals contract development and manufacturing organization Rentschler Biopharma is extending and deepening its existing collaboration in Japan with Summit Pharmaceuticals International (SPI), a wholly owned subsidiary of Sumitomo.

Why CDMOs Should Consider Value-Based Pricing

Continuous Processing

Experts Statements: Gabriel Haering, Cerbios Pharma

The pharmaceutical industry continues to grow and is estimated to be worth $1.5 trillion by 2021.

The Pharma CDMO Challenge

Arcinova Appoints Roger Kilburn as CEO

Ardena Launches Life Science Ingredients Arm

Olon Buys Indian API Plant

With this acquisition, Olon said it has successfully finalized its three-year development plan and will now move to its next target, which is to play an important role in manufacturing biologics APIs.

A Holistic System Approach

Unique Opportunity for Innovation and Improvement

A Visible Reference of Production-scale Micro Reaction Technology

A Technology on the Upswing

Benefits across Different Industries and Applications

Unsurpassed Heat and Mass Transfer Properties

Further Development Will Increase Confidence

A Boost to Efficiency, Adaptability and Responsiveness

Increased Process Performance and Safety

A Technology Whose Use is Indispensable

Flow Chemistry: Key Technology for Sustainable Processes

The Need for Innovation in Pharmaceutical Manufacturing

Francesca Scarpitta Joins Cerbios as Director of HPAI Manufacturing Units

Cerbios has appointed Francesca Scarpitta as director of the company’s high potency active ingredients (HPAIs) production units.

Cerbios Expands HPAI Manufacturing Capacity

Lugano, Switzerland-based chemical and biological API manufacturer Cerbios announced that its board of directors has approved the installation of a new production line in its building dedicated for high potency active ingredients (HPAIs).

DCAT Week 2019

MENA Pharmaceutical Market

Opportunities for Western CDMOs in China

M&A in Pharma and CRO/CMO Industry